Incyte shares are trading lower after BMO Capital downgraded the stock from Market Perform to Underperform and lowered its price target from $52 to $48.
Portfolio Pulse from Benzinga Newsdesk
Incyte shares are trading lower following a downgrade from BMO Capital, which changed its rating from Market Perform to Underperform and reduced the price target from $52 to $48.
July 02, 2024 | 11:10 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Incyte shares are trading lower after BMO Capital downgraded the stock from Market Perform to Underperform and lowered its price target from $52 to $48.
The downgrade from BMO Capital and the reduction in the price target are likely to negatively impact investor sentiment and lead to a short-term decline in Incyte's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100